Avantor, Inc. (NYSE:AVTR) is Cannon Global Investment Management LLC’s 9th Largest Position

Cannon Global Investment Management LLC increased its stake in Avantor, Inc. (NYSE:AVTR) by 39.6% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 32,100 shares of the company’s stock after acquiring an additional 9,100 shares during the period. Avantor comprises approximately 2.2% of Cannon Global Investment Management LLC’s portfolio, making the stock its 9th largest position. Cannon Global Investment Management LLC’s holdings in Avantor were worth $821,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its position in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after acquiring an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its position in Avantor by 565.5% during the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after buying an additional 1,131 shares during the period. Gladius Capital Management LP purchased a new stake in Avantor during the fourth quarter valued at about $42,000. Montag A & Associates Inc. purchased a new stake in Avantor during the fourth quarter valued at about $43,000. Finally, TFO Wealth Partners LLC boosted its position in Avantor by 203,100.0% during the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after buying an additional 2,031 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Performance

Shares of Avantor stock traded down $0.22 on Friday, hitting $21.20. 9,536,567 shares of the company’s stock were exchanged, compared to its average volume of 6,872,663. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. The stock has a market capitalization of $14.40 billion, a PE ratio of 54.36, a PEG ratio of 2.17 and a beta of 1.35. The company has a 50-day simple moving average of $23.73 and a 200-day simple moving average of $23.81. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $26.16.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the company posted $0.29 EPS. The business’s revenue was down 5.6% on a year-over-year basis. As a group, equities analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Analyst Ratings Changes

Several analysts have issued reports on AVTR shares. Barclays cut their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, April 18th. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, April 29th. Finally, Evercore ISI increased their price target on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $26.36.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.